Bank of Montreal
PDLI

Bank of Montreal’s PDL BioPharma, Inc. PDLI Stock Holding History

Bank of Montreal’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,472
Closed -$21K – 5264
2020
Q3 		$21K Sell
8,472
-4,027
-32% -$12.9K ﹤0.01% 3828
2020
Q2 		$35K Buy
12,499
+10,985
+726% +$34.7K ﹤0.01% 3603
2020
Q1 		$4K Sell
1,514
-813,897
-100% -$2.62M ﹤0.01% 3754
2019
Q4 		$2.65M Buy
815,411
+135,819
+20% +$394K ﹤0.01% 1721
2019
Q3 		$1.47M Sell
679,592
-3,996
-0.6% -$10.7K ﹤0.01% 1879
2019
Q2 		$2.15M Sell
683,588
-5,428
-0.8% -$17.6K ﹤0.01% 1650
2019
Q1 		$2.56M Buy
689,016
+78,030
+13% +$263K ﹤0.01% 1531
2018
Q4 		$1.77M Sell
610,986
-63
-0% -$173 ﹤0.01% 1589
2018
Q3 		$1.61M Buy
611,049
+980
+0.2% +$2.4K ﹤0.01% 1783
2018
Q2 		$1.43M Sell
610,069
-453,508
-43% -$1.27M ﹤0.01% 1811
2018
Q1 		$3.13M Buy
1,063,577
+175,876
+20% +$480K ﹤0.01% 1363
2017
Q4 		$2.43M Buy
887,701
+496,515
+127% +$1.53M ﹤0.01% 1499
2017
Q3 		$1.33M Buy
391,186
+1,000
+0.3% +$2.78K ﹤0.01% 1841
2017
Q2 		$964K Sell
390,186
-4,625
-1% -$10.6K ﹤0.01% 1998
2017
Q1 		$896K Buy
394,811
+363,450
+1,159% +$804K ﹤0.01% 1902
2016
Q4 		$69K Sell
31,361
-1,152
-4% -$3.21K ﹤0.01% 3000
2016
Q3 		$109K Sell
32,513
-16,237
-33% -$51.5K ﹤0.01% 2732
2016
Q2 		$153K Buy
48,750
+3,420
+8% +$11.4K ﹤0.01% 2607
2016
Q1 		$150K Sell
45,330
-30,509
-40% -$95.1K ﹤0.01% 2619
2015
Q4 		$270K Sell
75,839
-34,445
-31% -$144K ﹤0.01% 2255
2015
Q3 		$555K Sell
110,284
-2,834,957
-96% -$16.2M ﹤0.01% 1810
2015
Q2 		$18.9M Buy
2,945,241
+2,353,158
+397% +$15.8M 0.02% 538
2015
Q1 		$4.17M Sell
592,083
-1,742,327
-75% -$12.6M ﹤0.01% 1101
2014
Q4 		$18M Buy
2,334,410
+851,589
+57% +$6.74M 0.02% 514
2014
Q3 		$11.1M Buy
1,482,821
+228,558
+18% +$2.12M 0.01% 753
2014
Q2 		$12.1M Buy
1,254,263
+307,545
+32% +$2.74M 0.01% 727
2014
Q1 		$7.87M Buy
946,718
+222,284
+31% +$1.91M 0.01% 757
2013
Q4 		$6.12M Buy
724,434
+686,386
+1,804% +$5.78M 0.01% 773
2013
Q3 		$303K Sell
38,048
-795
-2% -$6.39K ﹤0.01% 2047
2013
Q2 		$300K Buy
+38,843
New +$303K ﹤0.01% 1996

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Bank of Montreal's PDLI Position: Q4 2020 in Review

Bank of Montreal sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 8,472 shares — an estimated $21K sold.

Bank of Montreal first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $18.9M in Q2 2015. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Bank of Montreal reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank of Montreal sold 8,472 PDL BioPharma, Inc. shares in Q4 2020, an estimated $21K.
  • Bank of Montreal first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Bank of Montreal's PDL BioPharma, Inc. position peaked at $18.9M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.